{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T08:19:18Z","timestamp":1787818758152,"version":"build-2784847793"},"reference-count":63,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Continuum"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1212\/con.0000000000000712","type":"journal-article","created":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T14:58:34Z","timestamp":1553785114000},"page":"381-407","source":"Crossref","is-referenced-by-count":56,"title":["Antiepileptic Drug Treatment of Epilepsy in Children"],"prefix":"10.1212","volume":"25","author":[{"given":"Ahsan N. V.","family":"Moosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"3","key":"e_1_3_1_2_2","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/brain\/awh726","article-title":"Natural history of treated childhood-onset epilepsy: Prospective, long-term population-based study","volume":"129","author":"Sillanp\u00e4\u00e4 M","year":"2006","unstructured":"Sillanp\u00e4\u00e4 M Schmidt D. Natural history of treated childhood-onset epilepsy: Prospective, long-term population-based study. Brain 2006;129(pt 3):617\u2013624. doi:10.1093\/brain\/awh726.","journal-title":"Brain"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2014.05.029"},{"issue":"5","key":"e_1_3_1_4_2","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"345","author":"Kwan P","year":"2000","unstructured":"Kwan P Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000;345(5):314\u2013319. doi:10.1056\/NEJM200002033420503.","journal-title":"N Engl J Med"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12550"},{"issue":"16","key":"e_1_3_1_6_2","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1212\/WNL.0000000000001487","article-title":"Evidence-based guideline: management of an unprovoked first seizure in adults: report of the guideline development subcommittee of the American Academy of Neurology and the American Epilepsy Society","volume":"84","author":"Krumholz A","year":"2015","unstructured":"Krumholz A Wiebe S Gronseth GS. Evidence-based guideline: management of an unprovoked first seizure in adults: report of the guideline development subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2015;84(16):1705\u20131713. doi:10.1212\/WNL.0000000000001487.","journal-title":"Neurology"},{"issue":"2","key":"e_1_3_1_7_2","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1212\/WNL.48.2.430","article-title":"The course of benign partial epilepsy of childhood with centrotemporal spikes: a meta-analysis","volume":"48","author":"Bouma PA","year":"1997","unstructured":"Bouma PA Bovenkerk AC Westendorp RG, Brouwer OF. The course of benign partial epilepsy of childhood with centrotemporal spikes: a meta-analysis. Neurology 1997;48(2):430\u2013437. doi:10.1212\/WNL.48.2.430.","journal-title":"Neurology"},{"issue":"2","key":"e_1_3_1_8_2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1212\/01.WNL.0000033622.27961.B6","article-title":"Practice parameter: treatment of the child with a first unprovoked seizure: report of the quality standards subcommittee of the American Academy of Neurology and the practice committee of the Child Neurology Society","volume":"60","author":"Hirtz D","year":"2003","unstructured":"Hirtz D Berg A Bettis D. Practice parameter: treatment of the child with a first unprovoked seizure: report of the quality standards subcommittee of the American Academy of Neurology and the practice committee of the Child Neurology Society. Neurology 2003;60(2):166\u2013175. doi:10.1212\/01.WNL.0000033622.27961.B6.","journal-title":"Neurology"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2012.05.004"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2016.11.022"},{"key":"e_1_3_1_11_2","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3389\/fneur.2017.00505","article-title":"Expert opinion on the management of Lennox-Gastaut syndrome: treatment algorithms and practical considerations","volume":"8","author":"Cross JH","year":"2017","unstructured":"Cross JH Auvin S Falip M. Expert opinion on the management of Lennox-Gastaut syndrome: treatment algorithms and practical considerations. Front Neurol 2017;8:505. doi:10.3389\/fneur.2017.00505.","journal-title":"Front Neurol"},{"issue":"2","key":"e_1_3_1_12_2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1212\/CON.0000000000000713","article-title":"Treatment of women with epilepsy","volume":"25","author":"Sazgar M","year":"2019","unstructured":"Sazgar M. Treatment of women with epilepsy. Continuum 2019;25(2, Epilepsy):408\u2013430. doi: 10.1212\/CON.0000000000000713.","journal-title":"Continuum"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2017.01.014"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12074"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60461-9"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60460-7"},{"key":"e_1_3_1_17_2","first-page":"CD011412","article-title":"Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data","volume":"6","author":"Nevitt SJ","year":"2017","unstructured":"Nevitt SJ Sudell M Weston J. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. Cochrane Database Syst Rev 2017;6:CD011412. doi:10.1002\/14651858.CD011412.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13981"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-018-0286-0"},{"issue":"5","key":"e_1_3_1_20_2","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/adc.2009.160606","article-title":"Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: a multi-centre randomised trial","volume":"95","author":"Darke K","year":"2010","unstructured":"Darke K Edwards SW Hancock E. Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: a multi-centre randomised trial. Arch Dis Child 2010;95(5):382\u2013386. doi:10.1136\/adc.2009.160606.","journal-title":"Arch Dis Child"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004806"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(16)30294-0"},{"issue":"24","key":"e_1_3_1_23_2","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1212\/WNL.0b013e318259e2cf","article-title":"Evidence-based guideline update: medical treatment of infantile spasms. Report of the guideline development subcommittee of the American Academy of Neurology and the practice committee of the Child Neurology Society","volume":"78","author":"Go CY","year":"2012","unstructured":"Go CY Mackay MT Weiss SK. Evidence-based guideline update: medical treatment of infantile spasms. Report of the guideline development subcommittee of the American Academy of Neurology and the practice committee of the Child Neurology Society. Neurology. 2012;78(24):1974\u20131980. doi:10.1212\/WNL.0b013e318259e2cf.","journal-title":"Neurology."},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17400-X"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24594"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(05)70199-X"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13557"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2008.01728.x"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13057"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13221"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2010.02657.x"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0902014"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003480"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12028"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2012.02.004"},{"issue":"1","key":"e_1_3_1_36_2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJM199301073280105","article-title":"Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome)","volume":"328","author":"Felbamate Study Group in Lennox-Gastaut Syndrome","year":"1993","unstructured":"Felbamate Study Group in Lennox-Gastaut Syndrome. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). N Engl J Med 1993;328(1):29\u201333. doi:10.1056\/NEJM199301073280105.","journal-title":"N Engl J Med"},{"issue":"25","key":"e_1_3_1_37_2","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJM199712183372504","article-title":"Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group","volume":"337","author":"Motte J","year":"1997","unstructured":"Motte J Trevathan E Arvidsson JF. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group. N Engl J Med 1997;337(25):1807\u20131812. doi:10.1056\/NEJM199712183372504.","journal-title":"N Engl J Med"},{"issue":"9","key":"e_1_3_1_38_2","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1212\/WNL.52.9.1882","article-title":"A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. topiramate YL study group","volume":"52","author":"Sachdeo RC","year":"1999","unstructured":"Sachdeo RC Glauser TA Ritter F. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. topiramate YL study group. Neurology. 1999;52(9):1882\u20131887. doi:10.1212\/WNL.52.9.1882.","journal-title":"Neurology."},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000303813.95800.0d"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318232de76"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30136-3"},{"issue":"2","key":"e_1_3_1_42_2","first-page":"CD003277","article-title":"Treatment of Lennox-Gastaut syndrome","author":"Hancock EC","year":"2013","unstructured":"Hancock EC Cross JH. Treatment of Lennox-Gastaut syndrome. Cochrane Database Syst Rev 2013;(2):CD003277. doi:10.1002\/14651858.CD003277.pub3.","journal-title":"Cochrane Database Syst Rev"},{"issue":"189","key":"e_1_3_1_43_2","first-page":"48950","article-title":"Schedules of controlled substances: placement in schedule V of certain FDA-approved drugs containing cannabidiol; corresponding change to permit requirements. Final order","volume":"83","author":"Drug Enforcement Administration, Department of Justice","year":"2018","unstructured":"Drug Enforcement Administration, Department of Justice. Schedules of controlled substances: placement in schedule V of certain FDA-approved drugs containing cannabidiol; corresponding change to permit requirements. Final order. Fed Regist 2018;83(189):48950\u201348953.","journal-title":"Fed Regist"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000266386.55715.3f"},{"key":"e_1_3_1_45_2","first-page":"583531","article-title":"Continuous spikes and waves during sleep: electroclinical presentation and suggestions for management","volume":"2013","author":"S\u00e1nchez Fern\u00e1ndez I","year":"2013","unstructured":"S\u00e1nchez Fern\u00e1ndez I Chapman KE Peters JM. Continuous spikes and waves during sleep: electroclinical presentation and suggestions for management. Epilepsy Res Treat 2013;2013:583531. doi:10.1155\/2013\/583531.","journal-title":"Epilepsy Res Treat"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12678"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13128"},{"key":"e_1_3_1_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2013.02.010"},{"key":"e_1_3_1_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13132"},{"issue":"12","key":"e_1_3_1_50_2","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S1474-4422(15)00199-4","article-title":"A roadmap for precision medicine in the epilepsies","volume":"14","author":"EpiPM Consortium","year":"2015","unstructured":"EpiPM Consortium. A roadmap for precision medicine in the epilepsies. Lancet Neurol 2015;14(12):1219\u20131228. doi:10.1016\/S1474-4422(15)00199-4.","journal-title":"Lancet Neurol"},{"key":"e_1_3_1_51_2","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2017.1253476"},{"key":"e_1_3_1_52_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21724"},{"issue":"9","key":"e_1_3_1_53_2","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1111\/epi.13461","article-title":"The SCN8A encephalopathy mutation p.Ile1327Val displays elevated sensitivity to the anticonvulsant phenytoin","volume":"57","author":"Barker BS","year":"2016","unstructured":"Barker BS Ottolini M Wagnon JL. The SCN8A encephalopathy mutation p.Ile1327Val displays elevated sensitivity to the anticonvulsant phenytoin. Epilepsia 2016;57(9):1458\u20131466. doi:10.1111\/epi.13461.","journal-title":"Epilepsia"},{"issue":"2","key":"e_1_3_1_54_2","first-page":"CD001902","article-title":"Early versus late antiepileptic drug withdrawal for people with epilepsy in remission","author":"Strozzi I","year":"2015","unstructured":"Strozzi I Norlan SJ Sperling MR. Early versus late antiepileptic drug withdrawal for people with epilepsy in remission. Cochrane Database Syst Rev 2015;(2):CD001902. doi:10.1002\/14651858.CD001902.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"e_1_3_1_55_2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1528-1167.2008.01923.x","article-title":"When is it safe to discontinue AED treatment?","volume":"49","author":"Camfield P","year":"2008","unstructured":"Camfield P Camfield C. When is it safe to discontinue AED treatment? Epilepsia 2008;49(suppl 9):25\u201328. doi:10.1111\/j.1528-1167.2008.01923.x.","journal-title":"Epilepsia"},{"key":"e_1_3_1_56_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000154517.82748.A7"},{"key":"e_1_3_1_57_2","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13761"},{"issue":"2","key":"e_1_3_1_58_2","first-page":"CD005003","article-title":"Rapid versus slow withdrawal of antiepileptic drugs","author":"Ranganathan LN","year":"2006","unstructured":"Ranganathan LN Ramaratnam S. Rapid versus slow withdrawal of antiepileptic drugs. Cochrane Database Syst Rev 2006;(2):CD005003. doi:10.1002\/14651858.CD005003.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_1_59_2","unstructured":"Food and Drug Administration. Diazepam rectal gel. accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/020648s014lbl.pdf. Updated December 2016. Accessed February 4 2019."},{"key":"e_1_3_1_60_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199806253382602"},{"issue":"5","key":"e_1_3_1_61_2","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1212\/WNL.51.5.1274","article-title":"Treating repetitive seizures with rectal diazepam formulation: a randomized study. The North American Diastat Study Group","volume":"51","author":"Cereghino JJ","year":"1998","unstructured":"Cereghino JJ Mitchell WG Murphy J. Treating repetitive seizures with rectal diazepam formulation: a randomized study. The North American Diastat Study Group. Neurology 1998;51(5):1274\u20131282.","journal-title":"Neurology"},{"issue":"7","key":"e_1_3_1_62_2","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJMoa1107494","article-title":"Intramuscular versus intravenous therapy for prehospital status epilepticus","volume":"366","author":"Silbergleit R","year":"2012","unstructured":"Silbergleit R Durkalski V Lowenstein D. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med 2012;366(7):591\u2013600. doi:10.1056\/NEJMoa1107494.","journal-title":"N Engl J Med"},{"issue":"5","key":"e_1_3_1_63_2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pediatrneurol.2005.09.006","article-title":"Intranasal midazolam vs rectal diazepam in acute childhood seizures","volume":"34","author":"Bhattacharyya M","year":"2006","unstructured":"Bhattacharyya M Kalra V Gulati S. Intranasal midazolam vs rectal diazepam in acute childhood seizures. Pedatr Neurol 2006;34(5):355\u2013359. doi:10.1016\/j.pediatrneurol.2005.09.006.","journal-title":"Pedatr Neurol"},{"issue":"9481","key":"e_1_3_1_64_2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0140-6736(05)66909-7","article-title":"Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial","volume":"366","author":"McIntyre J","year":"2005","unstructured":"McIntyre J Robertson S Norris E. Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial. Lancet 2005;366(9481):205\u2013210. doi:10.1016\/S0140-6736(05)66909-7.","journal-title":"Lancet"}],"container-title":["Continuum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00132979-201904000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T14:07:53Z","timestamp":1752156473000},"score":1,"resource":{"primary":{"URL":"https:\/\/continuum.aan.com\/doi\/10.1212\/CON.0000000000000712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["10.1212\/CON.0000000000000712"],"URL":"https:\/\/doi.org\/10.1212\/con.0000000000000712","relation":{},"ISSN":["1080-2371","1538-6899"],"issn-type":[{"value":"1080-2371","type":"print"},{"value":"1538-6899","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4]]}}}